Shrunken Pore Syndrome: A New and More Powerful Phenotype of Renal Dysfunction Than Chronic Kidney Disease for Predicting Contrast‐Associated Acute Kidney Injury

Li‐Wei Zhang,Man‐Qing Luo,Xian‐Wei Xie,Zhe‐Bin You,Ji‐Lang Zeng,Mao‐Qing Lin,Li‐Chuan Chen,Kai‐Yang Lin,Yan‐Song Guo

DOI: https://doi.org/10.1161/JAHA.122.027980

2022-12-26

Abstract:Background Shrunken pore syndrome (SPS) as a novel phenotype of renal dysfunction is characterized by a difference in renal filtration between cystatin C and creatinine. The manifestation of SPS was defined as a cystatin C–based estimated glomerular filtration rate (eGFR) <60% of the creatinine‐based eGFR. SPS has been shown to be associated with the progression and adverse prognosis of various cardiovascular and renal diseases. However, the predictive value of SPS for contrast‐associated acute kidney injury (CA‐AKI) and long‐term outcomes in patients undergoing percutaneous coronary intervention remains unclear. Methods and Results We retrospectively observed 5050 consenting patients from January 2012 to December 2018. Serum cystatin C and creatinine were measured and applied to corresponding 2012 and 2021 Chronic Kidney Disease Epidemiology Collaboration equations, respectively, to calculate the eGFR. Chronic kidney disease (CKD) was defined as a creatinine‐based eGFR <60 mL/min per 1.73 m 2 without dialysis. CA‐AKI was defined as an increase in serum creatinine ≥50% or 0.3 mg/dL within 48 hours after contrast medium exposure. Overall, 649 (12.85%) patients had SPS, and 324 (6.42%) patients developed CA‐AKI. Multivariate logistic regression analysis indicated that SPS was significantly associated with CA‐AKI after adjusting for potential confounding factors (odds ratio [OR], 4.17 [95% CI, 3.17–5.46]; P <0.001). Receiver operating characteristic analysis indicated that the cystatin C–based eGFR:creatinine‐based eGFR ratio had a better performance and stronger predictive power for CA‐AKI than creatinine‐based eGFR (area under the curve: 0.707 versus 0.562; P <0.001). Multivariate logistic analysis revealed that compared with those without CKD and SPS simultaneously, patients with CKD and non‐SPS (OR, 1.70 [95% CI, 1.11–2.55]; P =0.012), non‐CKD and SPS (OR, 4.02 [95% CI, 2.98–5.39]; P <0.001), and CKD and SPS (OR, 8.62 [95% CI, 4.67–15.7]; P <0.001) had an increased risk of CA‐AKI. Patients with both SPS and CKD presented the highest risk of long‐term mortality compared with those without both (hazard ratio, 2.30 [95% CI, 1.38–3.86]; P =0.002). Conclusions SPS is a new and more powerful phenotype of renal dysfunction for predicting CA‐AKI than CKD and will bring new insights for an accurate clinical assessment of the risk of CA‐AKI. Nonstandard Abbreviations and Acronyms CA‐AKI contrast‐associated acute kidney injury eGFRcr creatinine‐based estimated glomerular filtration rate eGFRcys cystatin C–based estimated glomerular filtration rate SCr serum creatinine SPS shrunken pore syndrome Clinical Perspective What Is New? Shrunken pore syndrome is a new and more powerful phenotype of renal dysfunction for predicting contrast‐associated acute kidney injury than chronic kidney disease and increased all‐cause mortality. Patients with both shrunken pore syndrome and chronic kidney disease presented the highest risk of contrast‐associated acute kidney injury and long‐term poor prognosis compared with those without. What Are the Clinical Implications? Shrunken pore syndrome is helpful to identify the risk population earlier and can be used in future studies of risk stratification during clinical practice. We suggest that optimal risk stratification of contrast‐associated acute kidney injury requires not only an analysis of the creatinine‐based estimated glomerular filtration rate and the urine albumin:creatinine ratio but also the cystatin C–based estimated glomerular filtration rate:creatinine‐based estimated glomerular filtration rate ratio to determine the presence of shrunken pore syndrome. Contrast‐associated acute kidney injury (CA‐AKI) is the third major pathogenic factor of acute kidney injury and 1 of the most common complications after percutaneous coronary intervention. 1 It is associated with longer hospital stays, more medical costs, and higher risks of developing end‐stage renal disease. 2 Early identification of -Abstract Truncated-